Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report

M Brunet, T Van Gelder, A Åsberg… - Therapeutic drug …, 2019 - journals.lww.com
Ten years ago, a consensus report on the optimization of tacrolimus was published in this
journal. In 2017, the Immunosuppressive Drugs Scientific Committee of the International …

Topoisomerases as anticancer targets

JL Delgado, CM Hsieh, NL Chan… - Biochemical Journal, 2018 - portlandpress.com
Many cancer type-specific anticancer agents have been developed and significant
advances have been made toward precision medicine in cancer treatment. However …

Drug-resistant epilepsy: multiple hypotheses, few answers

F Tang, AMS Hartz, B Bauer - Frontiers in neurology, 2017 - frontiersin.org
Epilepsy is a common neurological disorder that affects over 70 million people worldwide.
Despite the recent introduction of new antiseizure drugs (ASDs), about one-third of patients …

ABC family transporters

X Liu - Drug transporters in drug disposition, effects and …, 2019 - Springer
The transport of specific molecules across lipid membranes is an essential function of all
living organisms. The processes are usually mediated by specific transporters. One of the …

Exploring the impact of single-nucleotide polymorphisms on translation

F Robert, J Pelletier - Frontiers in genetics, 2018 - frontiersin.org
Over the past 15 years, sequencing of the human genome and The Cancer Genome Atlas
(TCGA) project have led to comprehensive lists of single-nucleotide polymorphisms (SNPs) …

Pharmacogenomics of drug metabolizing enzymes and transporters: relevance to precision medicine

S Ahmed, Z Zhou, J Zhou… - Genomics, proteomics and …, 2016 - academic.oup.com
The interindividual genetic variations in drug metabolizing enzymes and transporters
influence the efficacy and toxicity of numerous drugs. As a fundamental element in precision …

Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution

M Ryder, M Callahan, MA Postow… - Endocrine-related …, 2014 - erc.bioscientifica.com
Novel immune checkpoint blockade with ipilimumab, an antibody blocking the cytotoxic T-
lymphocyte antigen 4 (CTLA4), is revolutionizing cancer therapy. However, ipilimumab …

Mechanisms of cancer drug resistance

MM Gottesman - Annual review of medicine, 2002 - annualreviews.org
▪ Abstract The design of cancer chemotherapy has become increasingly sophisticated, yet
there is no cancer treatment that is 100% effective against disseminated cancer. Resistance …

The human ATP-binding cassette (ABC) transporter superfamily

M Dean, Y Hamon, G Chimini - Journal of lipid research, 2001 - ASBMB
The transport of specific molecules across lipid membranes is an essential function of all
living organisms and a large number of specific transporters have evolved to carry out this …

A "Silent" Polymorphism in the MDR1 Gene Changes Substrate Specificity

C Kimchi-Sarfaty, JM Oh, IW Kim, ZE Sauna… - Science, 2007 - science.org
Synonymous single-nucleotide polymorphisms (SNPs) do not produce altered coding
sequences, and therefore they are not expected to change the function of the protein in …